Figure 3.
Longitudinal lipidomic and CA-125 analyses of two exemplified ovarian cancer patients. At progression, the two-lipid signature was strongly elevated whereas CA-125 showed none or minor elevation. Preop1, before first surgery; Preop2, before second surgery; Treat, on-treatment; FU, follow-up; Prog, progression.